RESUMO
We present the case of a 73-year-old man, operated on for paralyzing sciatica, who displayed acute postoperative respiratory distress and intra-alveolar haemorrhage following the administration of dabigatran etexilate, a new oral antithrombin used in the prevention of venous thromboembolism. This serious incident occurred in a patient who had a 20-year history of chronic thrombocytopenia (platelet level at 100G/l) and a heparin-induced thrombocytopenia and in whom no other aetiology was found (tuberculosis, pneumo-renal syndrome, etc.). The postoperative prevention of thromboembolic events in a patient with high risk bleeding requires intensive monitoring, notably, when prescribing new drugs such as new anticoagulant agents.
Assuntos
Anticoagulantes/efeitos adversos , Antitrombinas/efeitos adversos , Benzimidazóis/efeitos adversos , Complicações Pós-Operatórias/induzido quimicamente , Piridinas/efeitos adversos , Síndrome do Desconforto Respiratório/induzido quimicamente , Doença Aguda , Idoso , Dabigatrana , Humanos , Masculino , Índice de Gravidade de DoençaRESUMO
Intoxication by glycyrrhizic acid is a well-known cause of the apparent mineralocorticoid excess syndrome. It causes hypokalemia by inhibiting the enzyme 11-beta-hydroxysteroid dehydrogenase. We report a case of hypokalemic rhabdomyolysis secondary to chronic glycyrrhizic acid intoxication.